Does Allopurinol Regress Left Ventricular Hypertrophy in Patients With Treated Essential Hypertension? (The ALLAY-EH Trial)

Project Details

StatusFinished
Effective start/end date1/02/1431/10/17

Funding

  • British Heart Foundation (PG/13/67/30444): £298,414.00

Research Output

Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension

Gingles, C., Symon, R., Gandy, S., Struthers, A., Houston, G., MacDonald, T., Lang, C., Donnan, P. & George, J., Dec 2019, In : Journal of Hypertension. 37, 12, p. 2481-2489 9 p.

Research output: Contribution to journalArticle

Open Access
File
  • 4 Citations (Scopus)
    159 Downloads (Pure)

    Plasma Desmosine and Abdominal Aortic Aneurysm Disease

    Mordi, I., Forsythe, R., Gellatly, C., Iskandar, Z., McBride, O., Saratzis, A., Chalmers, R., Chin, C. W. L., Bown, M. J., Newby, D. E., Lang, C., Huang, J. & Choy, A., 15 Oct 2019, In : Journal of the American Heart Association. 8, 20, p. 1-9 9 p., e013743.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 1 Citation (Scopus)
    85 Downloads (Pure)